It will be important to determine whether any CAPN5 polymorphisms are risk factors for patients with the ADNIV-like diseases, such as uveitis, diabetic retinopathy, retinitis pigmentosa, or proliferative vitreoretinopathy. Here, CAPN5 is linked to diabetic retinopathy.